Comparison of antiplatelet treatment in patients with clopidogrel nonresponders with or without carriage of CYP2C19 polymorphism.

Ko YM, Kim JK, Kim JH, Park SH, Choi RK

Open source

DOI
10.3904/kjim.2017.363.r1
Published
2026 Sep
Container
The Korean journal of internal medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3904/kjim.2017.363.r1,
  title = {Comparison of antiplatelet treatment in patients with clopidogrel nonresponders with or without carriage of CYP2C19 polymorphism.},
  author = {Ko YM and Kim JK and Kim JH and Park SH and Choi RK},
  year = {2026},
  journal = {The Korean journal of internal medicine},
  doi = {10.3904/kjim.2017.363.r1},
  url = {https://doi.org/10.3904/kjim.2017.363.r1}
}

RIS

TY  - JOUR
TI  - Comparison of antiplatelet treatment in patients with clopidogrel nonresponders with or without carriage of CYP2C19 polymorphism.
AU  - Ko YM
AU  - Kim JK
AU  - Kim JH
AU  - Park SH
AU  - Choi RK
PY  - 2026
JO  - The Korean journal of internal medicine
DO  - 10.3904/kjim.2017.363.r1
UR  - https://doi.org/10.3904/kjim.2017.363.r1
ER  - 

APA

YM, K., JK, K., JH, K., SH, P., & RK, C. (2026). Comparison of antiplatelet treatment in patients with clopidogrel nonresponders with or without carriage of CYP2C19 polymorphism.. The Korean journal of internal medicine. https://doi.org/10.3904/kjim.2017.363.r1

Source records